INTERNAL QUALITY CONTROL
Choosing control materials for the question
Independence, stability and suitable behaviour matter. No supplier label guarantees all three.
Revised 30 September 2026. The original publication date and address are retained.
Separate characteristics that can overlap
Assayed or unassayed describes whether assigned values are supplied. First-party, third-party or in-house describes origin. A third-party control can also be assayed. These are not four mutually exclusive categories.
| Characteristic | Check in practice |
|---|---|
| Concentration | Does it challenge relevant parts of the measuring interval? |
| Stability and handling | Are storage, reconstitution and in-use conditions suitable? |
| Behaviour | Does it respond appropriately to the errors the control plan should detect? |
| Independence | Could shared manufacture or value assignment hide a relevant problem? |
| Assigned values | How were they established, and what do the supplied ranges mean? |
Independence is useful; “unbiased” is too strong
A material independent of the reagent or instrument supplier can help reveal failures that a more closely linked control misses. It can still have matrix effects, unsuitable concentrations or limitations in assigned values. Third-party origin does not establish commutability, trueness or platform-independent performance.
Keep the calibration chain distinct
An IQC material used to monitor precision need not itself function as a certified reference material. A control target is not automatically a traceable reference value, and its acceptance range is not a calibrator uncertainty certificate. Establish traceability for the patient-result measurement procedure through the relevant calibration information.
A lot change is evidence to investigate
When a new control lot shifts but patient comparisons remain stable, examine material behaviour and target assignment. When patient results shift too, investigate the measurement procedure. Do not assume either explanation solely from the supplier’s label.
Use the data for MU with the right boundary
Control degradation or poor reconstitution can inflate variability that is not representative of routine patient measurement. Conversely, an unusually stable material may fail to represent important patient-specimen effects. Plot the data, document investigations and justify inclusion or exclusion; do not simply choose the control or data subset that gives the smallest MU.
Improve control selection without casually modifying the assay
Recovery or linearity checks can raise questions, but do not by themselves prove commutability. Changing reagent concentrations, dilution schemes or assay conditions requires appropriate method evaluation and change control. It is not a routine fix for an inconvenient control result.
Sources & further reading
- CLSI C24 — statistical quality-control strategy (public overview)
- ISO/TS 20914 — medical laboratory MU (public scope)
- JCGM 200 — metrological traceability and material terminology
Educational material. Examples are synthetic. Consult applicable full guidance and your locally approved procedure for operational decisions.
Take the next step
Connect control-material selection with routine monitoring and review.
- Internal quality control guide — Understand what a control signal can tell you and when to ask for help.
- Free IQC review pack — Use a one-page sheet and fictional example to record a problem and the next review.
- External quality assessment guide — Read why a scheme sample may behave differently from patient samples.
Free Word and PDF pack with fictional examples. No payment or account required. Newsletter and course sign-ups are separate.